scispace - formally typeset
R

Rui Zeng

Researcher at Huazhong University of Science and Technology

Publications -  72
Citations -  1910

Rui Zeng is an academic researcher from Huazhong University of Science and Technology. The author has contributed to research in topics: Kidney disease & Medicine. The author has an hindex of 18, co-authored 59 publications receiving 1185 citations.

Papers
More filters
Journal ArticleDOI

Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia.

TL;DR: Renal abnormalities occurred in the majority of patients with COVID-19 pneumonia, and patients with renal involvement had higher overall mortality compared with those without renal involvement, and severity of pneumonia was the risk factor most commonly associated with lower odds of proteinuric or hematuric remission and recovery from AKI.
Journal ArticleDOI

XJB-5-131 inhibited ferroptosis in tubular epithelial cells after ischemia-reperfusion injury

TL;DR: It is found that ferroptosis appeared in tubular epithelial cells of various human kidney diseases and the upregulation of tubular proferroptotic gene ACSL4 was correlated with renal function in patients with acute kidney tubular injury.
Journal ArticleDOI

Adipose-derived mesenchymal stem cells employed exosomes to attenuate AKI-CKD transition through tubular epithelial cell dependent Sox9 activation.

TL;DR: It is found that hAD-MSC treatment upregulated the expression of tubular Sox9, promoted tubular regeneration, attenuated AKI, and mitigated subsequent renal fibrosis, but these beneficial effects were abolished by a drug inhibiting the release of exosomes from hAD.
Journal ArticleDOI

The probiotic L. casei Zhang slows the progression of acute and chronic kidney disease

TL;DR: This article showed that probiotic Lactobacillus casei Zhang (L.casei Zhang) corrected bilateral renal ischemia-reperfusion (I/R)-induced gut microbial dysbiosis, alleviated kidney injury, and delayed its progression to CKD in mice.
Journal ArticleDOI

Biliverdin Reductase Mediates Hypoxia-Induced EMT via PI3-Kinase and Akt

TL;DR: Using small interfering RNA to knockdown biliverdin reductase, it is demonstrated that the enzyme associates with phosphorylated Akt and mediates the hypoxia-induced EMT phenotype through a PI3K/Akt-dependent pathway.